We are live on ! Find out more
ITCI

Intra-Cellular Therapies Inc.
ITCI

Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

74 hedge funds and large institutions have $405M invested in Intra-Cellular Therapies Inc. in 2015 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 24 increasing their positions, 11 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

900% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 3

118% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 11

88% more capital invested

Capital invested by funds: $215M → $405M (+$189M)

57% more funds holding

Funds holding: 47 → 74 (+27)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
74
Holders Change
+27
Holders Change %
+57.45%
% of All Funds
1.97%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
30
Increased
24
Reduced
11
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WA
Wasatch Advisors
Utah
+$22.4M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$18.6M
3
BFA
BlackRock Fund Advisors
California
+$11.2M
4
BIT
BlackRock Institutional Trust
California
+$6.17M
5
VAM
Visium Asset Management
New York
+$6.16M

Top Sellers

Rank Fund Capital Flow
1
RG
Redmile Group
California
-$7.22M
2
Franklin Resources
Franklin Resources
California
-$2.96M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$2.24M
4
BG
BlackRock Group
United Kingdom
-$1.25M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$872K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
$3M +$2.82M +125,723 New
BBA
27
Baker Bros. Advisors
New York
$2.49M +$2.33M +104,166 New
Bank of New York Mellon
28
Bank of New York Mellon
New York
$2.41M +$350K +15,622 +18%
SM
29
Sabby Management
Florida
$2.39M +$2.24M +100,000 New
BlackRock
30
BlackRock
New York
$2.32M – – –
Point72 Asset Management
31
Point72 Asset Management
Connecticut
$2.15M +$2.01M +89,823 New
WMSA
32
Weiss Multi-Strategy Advisers
New York
$1.91M +$1.23M +55,000 +220%
Charles Schwab
33
Charles Schwab
California
$1.54M +$85.5K +3,817 +6%
TCIM
34
TIAA CREF Investment Management
New York
$1.54M -$45.5K -2,033 -3%
MIM
35
Monashee Investment Management
Massachusetts
$1.53M +$1.43M +63,978 New
CS
36
Credit Suisse
Switzerland
$1.14M +$1.07M +47,794 New
EI
37
EAM Investors
California
$1.1M +$1.03M +46,132 New
State of New Jersey Common Pension Fund D
38
State of New Jersey Common Pension Fund D
New Jersey
$1.07M – – –
Renaissance Technologies
39
Renaissance Technologies
New York
$1.03M +$963K +43,000 New
RFC
40
Russell Frank Company
Washington
$955K +$896K +39,995 New
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$867K +$103K +4,600 +15%
Ohio Public Employees Retirement System (OPERS)
42
Ohio Public Employees Retirement System (OPERS)
Ohio
$699K +$655K +29,260 New
Swiss National Bank
43
Swiss National Bank
Switzerland
$580K +$164K +7,300 +43%
TA
44
Teachers Advisors
New York
$575K – – –
CIA
45
Capital Impact Advisors
Massachusetts
$514K +$482K +21,518 New
Two Sigma Investments
46
Two Sigma Investments
New York
$500K +$469K +20,947 New
Alyeska Investment Group
47
Alyeska Investment Group
Illinois
$452K -$872K -38,945 -67%
TC
48
TFS Capital
Pennsylvania
$378K +$354K +15,822 New
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$357K +$62.7K +2,800 +23%
Goldman Sachs
50
Goldman Sachs
New York
$349K +$327K +14,604 New
1
2
3 4

ITCI Hedge Fund Activity: Q1 2015 in Review

74 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Intra-Cellular Therapies Inc. (ITCI) for Q1 2015, worth a combined $405M — up 88% from $215M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new ITCI positions and 3 closed out — a net gain of 27 holders — while 24 added to existing stakes and 11 trimmed.

The largest buyer was Wasatch Advisors, opening a new position worth an estimated $22.4M. The largest seller was Redmile Group, cutting an estimated $7.22M.

  • 74 institutional investors held Intra-Cellular Therapies Inc. (ITCI) as of Q1 2015, up from 47 in Q4 2014.
  • Funds reported $405M of Intra-Cellular Therapies Inc. stock for Q1 2015, up 88% quarter-over-quarter.
  • 30 funds opened new Intra-Cellular Therapies Inc. positions in Q1 2015 and 3 closed out, a net change of +27 holders.
  • The largest Intra-Cellular Therapies Inc. buyer in Q1 2015 was Wasatch Advisors, an estimated $22.4M added.
  • The largest Intra-Cellular Therapies Inc. seller in Q1 2015 was Redmile Group, an estimated $7.22M sold.

Based on aggregated 13F filings for Q1 2015.